Tachykinin NK1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus

European Journal of Pharmacology

Volumn 348, Issue 2-3, 1998, Pages 155-160

  Hahn, Maureen K ^a   Bannon, Michael J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

c fos; Locus coeruleus; Neurokinin receptor; Stress; Substance P; Tachykinin NK1 receptor

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; LANEPITANT; LY 306740; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; NOLPITANTIUM; SUBSTANCE P; UNCLASSIFIED DRUG; ACETAMIDE DERIVATIVE; ANALGESIC AGENT; INDOLE DERIVATIVE; PIPERIDINE DERIVATIVE; QUINUCLIDINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LOCUS CERULEUS; NEUROTRANSMISSION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; STRESS; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; EXERCISE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; ONCOGENE; STEREOISOMERISM; SYNAPTIC TRANSMISSION;

ACETAMIDES; ANALGESICS; ANIMALS; GENE EXPRESSION REGULATION; GENES, FOS; INDOLES; LOCUS COERULEUS; PIPERIDINES; QUINUCLIDINES; RATS; RECEPTORS, NEUROKININ-1; RESTRAINT, PHYSICAL; STEREOISOMERISM; STRESS; SUBSTANCE P; SYNAPTIC TRANSMISSION;

EID: 0032495868     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00150-2     Document Type: Article

References (41)

1. Abercrombie E.D., Jacobs B.L. Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats: I. Acutely presented stressful and nonstressful stimuli. J. Neurosci. 7:1987;2837-2843.
2. Aston-Jones G., Chiang C., Alexinsky T. Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. Prog. Brain Res. 88:1991;501-520.
3. Bannon M.J., Elliott P.J., Alpert J.E., Goedert M., Iversen S.D., Iversen L.L. Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurons. Nature. 306:1983;791-792.
4. Beck C.H.M., Fibiger H.C. Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment. J. Neurosci. 15:1995;709-720.
5. Bonaz B., Tache Y. Water-avoidance stress-induced c-fos expression in the rat brain and stimulation of fecal output: role of corticotropin-releasing factor. Brain Res. 641:1994;21-28.
6. Buck S.H., Helke C.J., Burcher E., Shults C.W., O'Donohue T.L. Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system. Peptides. 7:1986;1109-1120.
7. Ceccatelli S., Villar M.J., Goldstein M., Hokfelt T. Expression of c-Fos immunoreactivity in transmitter-characterized neurons after stress. Proc. Natl. Acad. Sci. USA. 86:1989;9569-9573.
8. Chapman V., Buritova J., Honore P., Besson J. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-fos expression. J. Neurophysiol. 76:1996;1817-1827.
9. Chen X., Herbert J. Regional changes in c-fos expression in the basal forebrain and brainstem during adaptation to repeated stress: correlations with cardiovascular, hypothermic and endocrine responses. Neuroscience. 64:1995;675-685.
10. Cullinan W.E., Herman J.P., Battaglia D.F., Akil H., Watson S.J. Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience. 64:1995;477-505.
11. Culman J., Unger T. Central tachykinins: mediators of defence reaction and stress reactions. Can. J. Physiol. Pharmacol. 73:1995;885-891.
12. Culman J., Itoi K., Unger T. Hypothalamic tachykinins. Mediators of stress responses? Ann. New York Acad. Sci. 771:1995;204-218.
13. 11]-substance P Brain Res. 531:1990;333-337.
14. Emonds-Alt X., Doutremepuich J.-D., Heaulme M., Neliat G., Santucci V., Steinberg R., Vilain P., Bichon D., Ducoux J.-P., Proietto V., Van Broeck D., Soubrie P., Le Fur G., Breliere J.-C. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur. J. Pharmacol. 250:1993;403-413.
15. Fritschy J.M., Frondoza C.G., Grzanna R. Differential effects of reserpine on brainstem catecholaminergic neurons revealed by Fos protein immunohistochemistry. Brain Res. 562:1991;48-56.
16. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J.-F., Blanchard J.-C., Laduron P.M. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc. Natl. Acad. Sci. USA. 88:1991;10208-10212.
17. Grant S.J., Bittman K., Benno R.H. Both phasic sensory stimulation and tonic pharmacological activation increase fos-like immunoreactivity in the rat locus coeruleus. Synapse. 12:1992;112-118.
18. Guyenet P.G., Aghajanian G.K. Excitation of neurons in the locus coeruleus by substance P and related peptides. Brain Res. 136:1977;178-184.
19. Helke C.J., Krause J.E., Mantyh P.W., Couture R., Bannon M.J. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors and regulatory mechanisms. FASEB J. 4:1990;1606-1615.
20. Hipskind P.A., Howbert J.J., Bruns R.F., Cho S.S.Y., Crowell T.A., Foreman M.M., Gehlert D.R., Iyengar S., Johnson K.W., Krushinski J.H., Li D.L., Lobb K.L., Mason N.R., Muehl B.S., Nixon J.A., Phebus L.A., Regoli D., Simmons R.M., Threlkeld P.G., Waters D.C., Gitter B.D. 3-Aryl-1,2-diacetamidopropane derivatives as novel and potent NK-1 receptor antagonists. J. Med. Chem. 39:1996;736-748.
21. Jung M., Calassi R., Maruani J., Barnouin M.C., Souilhac J., Poncelet M., Gueudet C., Emonds-Alt X., Soubrie P., Breliere J.C., Le Fur C. Neuropharmacological characterization of SR 140333, a non-peptide antagonist of NK1 receptors. Neuropharmacology. 33:1994;167-179.
22. Maeno H., Kiyama H., Tohyama M. Distribution of the substance P receptor (NK-1 receptor) in the central nervous system. Mol. Brain Res. 18:1993;43-58.
23. Mantyh P.W., Gates T., Mantyh C.R., Maggio J.E. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J. Neurosci. 9:1989;258-279.
24. McCarson K.E., Krause J.E. The neurokinin-1 receptor antagonist LY306,740 blocks nociception-induced increases in dorsal horn neurokinin-1 receptor gene expression. Mol. Pharmacol. 50:1996;1189-1199.
25. Morgan J.I., Cohen D.R., Hempstead J.L., Curran T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science. 237:1987;192-197.
26. Otsuka M., Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73:1993;229-308.
27. Page M.E., Valentino R.J. Locus coeruleus activation by physiological challenges. Brain Res. Bull. 35:1994;557-560.
28. Palkovits M., Baffi J.S., Dvori S. Neuronal organization of stress response. Pain-induced c-fos expression in brain stem catecholaminergic cell groups. Ann. N.Y. Acad. Sci. 771:1995;313-326.
29. Patacchini R., Maggi C.A. Tachykinin receptors and receptor subtypes. Arch. Int. Pharmacodyn. Ther. 329:1995;161-184.
30. Pickel V.M., Joh T.H., Reis D.J., Leeman S.E., Miller R.J. Electron microscopic localization of substance P and enkephalin in axon terminals related to dendrites of catecholaminergic neurons. Brain Res. 160:1979;387-400.
31. Rasmussen K., Morilak D.A., Jacobs B.L. Single unit activity of locus coeruleus neurons in the freely moving cat: I. During naturalistic behaviors and in response to simple and complex stimuli. Brain Res. 371:1986;324-334.
32. Redmond Jr., D.E., 1987. Studies of the nucleus locus coeruleus in monkeys and hypotheses for neuropsychopharmacology. In: Meltzer, H.Y. (Ed.), The Third Generation of Progress. Raven Press, New York, NY, pp. 967-975.
33. Saffroy M., Beaujouan J.-C., Torrens Y., Besseyre J., Bergstrom L., Glowinski J. Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain. Peptides. 9:1988;227-241.
34. Sagar S.M., Sharp F.R., Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science. 240:1988;1328-1331.
35. Siegel R.A., Duker E.-M., Pahnke U., Wuttke W. Stress-induced changes in cholecystokinin and substance P concentrations in discrete regions of the hypothalamus. Neuroendocrinology. 46:1987;75-81.
36. Svensson T.H. Peripheral, autonomic regulation of locus coeruleus noradrenergic neurons in brain: putative implications for psychiatry and psychopharmacology. Psychopharmacology. 92:1987;1-7.
37. Takayama H., Ota Z., Ogawa N. Effect of immobilization stress on neuropeptides and their receptors in the rat central nervous system. Regul. Pept. 15:1986;239-248.
38. Teixeira R.M., Santos A.R.S., Ribeiro S.J., Calixto J.B., Rae G.A., DeLima T.C.M. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. Eur. J. Pharmacol. 311:1996;7-14.
39. Watanabe Y., Stone E., McEwen B.S. Induction and habituation of c-fos and zif/268 by acute and repeated stressors. NeuroReport. 5:1994;1321-1324.
40. Weiss J.M., Stout J.C., Aaron M.F., Quan N., Owens M.J., Butler P.D., Nemeroff C.B. Depression and anxiety: role of the locus coeruleus and corticotropin-releasing factor. Brain Res. Bull. 35:1994;561-572.
41. Zernig G., Troger J., Saria A. Differential behavioral profiles of the non-peptide substance P (NK1) antagonists CP-96,345 and RP 67580 in Swiss albino mice in the black-and-white box. Neurosci. Lett. 151:1993;64-66.